Exact Sciences Corporation (EXAS) Slid on Fear of Competition
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Posts Tagged ‘NASDAQ:EXAS’
10 High PE Stocks Insiders Are Buying
Insider buying represents one of the most reliable signals that investors and analysts use to gauge the business outlook of the company.
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2025 Earnings Call Transcript
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2025 Earnings Call Transcript May 1, 2025Exact Sciences Corporation beats earnings expectations.
Billionaire George Soros’ 10 Small-Cap Stocks with Huge Upside Potential
When a legendary investor like George Soros makes a move, Wall Street pays attention.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Should You Invest in Exact Sciences Corp. (EXAS)?
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 investor letter.
Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Cash-Rich Mid Cap Stocks To Buy Now
Cash flow is the money moving in and out of a business over a set period.
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2024 Earnings Call Transcript
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2024 Earnings Call Transcript February 19, 2025Exact Sciences Corporation misses on earnings expectations.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2024 Earnings Call Transcript
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2024 Earnings Call Transcript November 5, 2024Exact Sciences Corporation reports earnings inline with expectations.
Exact Sciences Corporation (EXAS) Bounced Back in Q3
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Buzzing AI Health Stocks
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively...
Should You Hold Exact Sciences Corporation (EXAS)?
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its second quarter 2024 investor letter. A copy of the fund can be downloaded here.
Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)?
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Baron Opportunity Fund Sold its Stake in Exact Sciences Corp (EXAS)
Baron Funds, an investment management company, released its “Baron Opportunity Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2024 Earnings Call Transcript
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2024 Earnings Call Transcript July 31, 2024Exact Sciences Corporation beats earnings expectations.
Exact Sciences Corporation (EXAS) Slipped Over Investors’ Concerns
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Is Exact Sciences Corporation (NASDAQ:EXAS) the Gene Therapy Stock with the Greatest Potential?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Exact Sciences Corporation (NASDAQ:EXAS) is the gene therapy stock...
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
Hedge Funds are Bullish on This Cancer Stock
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why hedge funds have sizable positions in Exact Sciences Corporation...
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Danica, and I will be your conference operator today.
Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Here’s Why Exact Sciences Corporation (EXAS) Declined in Q1
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2023 Earnings Call Transcript
Exact Sciences Corporation beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.53.
Top 5 CRISPR Stocks To Invest In
In this article, we discuss the top 5 CRISPR stocks to invest in.
5 Most Promising Gene Editing Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
5 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 5 most promising healthcare stocks according to analysts.
Ark Invest Stock Portfolio: 16 Biggest Positions
In this article, we discuss the 16 biggest positions in the ARK Invest portfolio.
Exact Sciences Corporation (EXAS) Shares Pulled Back in Q3
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
15 Stocks with Consistent Growth
In this article, we will take a look at the 15 stocks with consistent growth.
Ark Invest Stock Portfolio: Top 11 Picks
In this piece, we will take a look at Cathie Wood and Ark Invest's latest stock picks.
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Exact Sciences Third Quarter 2023 Earnings Conference Call.
15 Best ARK Stocks To Buy Now
Cathie Wood’s flagship ARK Innovation ETF made a roaring comeback earlier this year when investors’ risk appetite increased and growth stocks rebounded.
Exact Sciences Corporation (EXAS) Declined on Disappointing Financial Results
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Exact Sciences Corporation (EXAS) Rallied on Reporting Strong Results
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Ark Invest Stock Portfolio: Top 11 Picks
In this article, we discuss the top 11 stock picks of ARK Invest.
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the Exact Sciences Second Quarter 2023 Earnings Call. Today's call is being recorded.
Does Exact Sciences Corporation (EXAS) Have a Long Runway for Growth?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Booming Stocks to Buy Now
In this article, we discuss the 5 best booming stocks to buy now.
Should You Invest in Exact Sciences Corporation (EXAS) Now?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Jordan, and I'll be your conference operator today.
5 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Cathie Wood’s Stock Portfolio: Top 5 Stock Picks For 2023
In this article, we will look at Cathie Wood's top 5 stock picks for 2023.
5 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2022 Earnings Call Transcript
Operator: Good morning. My name is Rob and I will be your conference operator today.
Ark Invest Stock Portfolio: 5 Biggest Positions
In this article, we discuss the 5 biggest positions in the ARK Invest portfolio.
5 Best ARK Stocks To Buy Now
In this article, we discuss the 5 best ARK stocks to buy now.
